Andrew Peller (ADW) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
24 Nov, 2025Executive summary
Q1 2026 revenue was $99.2 million, stable year-over-year, with strong performance in western Canada and big box channels offsetting softness in Ontario retail and personal winemaking.
EBITDA increased 25.4% to $16.1 million, driven by margin expansion, cost savings, and operational efficiencies.
Net income improved to $4.6 million from a net loss of $0.4 million in Q1 2025.
Domestic wine volume grew as consumers favored Canadian-made products, offsetting declines in agency and personal winemaking businesses.
The company completed the sale of a non-core seven-acre land parcel in BC for $1.3 million, supporting its strategy to focus on high-return assets.
Financial highlights
Q1 sales were $99.2 million, nearly flat compared to $99.5 million in Q1 2025, with growth in grocery and big box channels offset by standalone retail declines.
Gross margin rose to $42 million (42.4%), up from 38.4% last year, aided by a $20 million cost-savings program and the Ontario Grape Support Program.
Excluding the Ontario Grape Support Program, gross margin was 40.2%, still showing strong year-over-year growth.
EBITDA increased to $16.1 million, up from $12.9 million in Q1 last year.
Interest expense decreased by nearly 15% due to lower debt and interest rates.
Outlook and guidance
Optimism for the remainder of fiscal 2026, with a strong balance sheet and continued focus on cost savings and operational efficiency.
The company expects to benefit from sustained consumer preference for domestic wines and supportive government policies.
Harvest outlook is positive, with strong expectations in Ontario and improving conditions in the west.
Focus remains on margin expansion, profitability, and free cash flow.
Management aims for sustained long-term value through above-category sales and EBITDA growth.
Latest events from Andrew Peller
- Q3 2026 delivered 3.3% sales growth, record margins, and higher EBITA, with net debt reduced.ADW
Q3 20263 Mar 2026 - Record margins and innovation in health-focused products drive growth and future opportunities.ADW
Planet MicroCap Showcase: TORONTO 20253 Feb 2026 - Margin and EBITDA growth, cost savings, and retail gains drive improved results and outlook.ADW
Q4 20243 Feb 2026 - EBITDA/EBITA grew to $12.9M despite a 1% sales drop, driven by cost savings and efficiency.ADW
Q1 20252 Feb 2026 - Revenue and EBITDA rose, but net earnings fell; retail and support programs drove growth.ADW
Q2 202515 Jan 2026 - Q3 2025 net earnings rose to $7.7M on 5.2% revenue growth and margin expansion.ADW
Q3 202524 Dec 2025 - Q2 2026 saw margin and earnings growth, offsetting lower revenue and boosting outlook.ADW
Q2 202613 Nov 2025 - Net earnings rebounded to $11.1M on record revenue, margin gains, and lower debt.ADW
Q4 202513 Nov 2025 - Strong asset base, broad distribution, and strategic focus drive sustained profitability.ADW
Investor Presentation2 Jul 2025